The complexities and nuances of life science startup companies can often be a black box to traditional tech investors. Not only do their life cycles tend to be longer, but the specific domain expertise and regulatory hurdles that are required to navigate the waters have often been barriers for investors not familiar with the industry. Come learn about the primary factors that differentiate life science startups from traditional tech investment opportunities from IntuitiveX, the leading life science consultancy and incubator based in Seattle.
